News on Pan Diagnostics Limited from BioPortfolio.com http://www.BioPortfolio.com Consolidated Pan Diagnostics Limited news from BioPortfolio.com Tue, 09 Feb 2010 22:24:58 GMT en Tecan and Enigma Diagnostics sign global manufacturing and supply agreement for point-of-care Molecular Diagnohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027663&HITNO=0&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027663&THISHREF=http://c.moreover.com/click/here.pl%3fz2532288722%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027663&HITNO=0&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027663&THISHREF=http://c.moreover.com/click/here.pl%3fz2532288722%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBionity.com: Tecan and Enigma ink manufacturing, supply agreement for molecular diagnostics instrumentshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024828&HITNO=1&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024828&THISHREF=http://c.moreover.com/click/here.pl%3fz2529212679%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024828&HITNO=1&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024828&THISHREF=http://c.moreover.com/click/here.pl%3fz2529212679%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Tecan and Enigma Diagnostics enter into manufacturing and supply agreement for Enigma's ML instrumentshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020297&HITNO=2&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020297&THISHREF=http://c.moreover.com/click/here.pl%3fz2526694800%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020297&HITNO=2&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020297&THISHREF=http://c.moreover.com/click/here.pl%3fz2526694800%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Tecan and Enigma Diagnostics Sign Global Manufacturing and Supplyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020656&HITNO=3&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020656&THISHREF=http://c.moreover.com/click/here.pl%3fz2526923671%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020656&HITNO=3&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020656&THISHREF=http://c.moreover.com/click/here.pl%3fz2526923671%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comUlitzer: Tecan and Enigma Diagnostics sign global manufacturing and supply agreement for point-of-care Molecular Diagnohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020303&HITNO=4&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020303&THISHREF=http://c.moreover.com/click/here.pl%3fz2526696383%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020303&HITNO=4&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020303&THISHREF=http://c.moreover.com/click/here.pl%3fz2526696383%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Tecan and Enigma Diagnostics enter into manufacturing and supply agreement for Enigma's ML instrumentshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019956&HITNO=5&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019956&THISHREF=http://c.moreover.com/click/here.pl%3fz2526537426%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019956&HITNO=5&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019956&THISHREF=http://c.moreover.com/click/here.pl%3fz2526537426%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Tecan Group, Enigma Diagnostics sign manufacturing and supply agreement for Enigma ML instrumentshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019221&HITNO=6&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019221&THISHREF=http://c.moreover.com/click/here.pl%3fz2526183264%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019221&HITNO=6&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019221&THISHREF=http://c.moreover.com/click/here.pl%3fz2526183264%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: First Treatment To Improve Survival In 20 Years Now Available For Patients With Osteosarcoma (Bone Cancer)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4007457&HITNO=7&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4007457&THISHREF=http://c.moreover.com/click/here.pl%3fz2521141699%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4007457&HITNO=7&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4007457&THISHREF=http://c.moreover.com/click/here.pl%3fz2521141699%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: First Treatment to Improve Survival in 20 Yearshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995554&HITNO=8&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995554&THISHREF=http://c.moreover.com/click/here.pl%3fz2515731023%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995554&HITNO=8&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995554&THISHREF=http://c.moreover.com/click/here.pl%3fz2515731023%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmiWeb: Starpharma Holdings Limited (SPHRY.PK) is One to Watchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000457&HITNO=9&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000457&THISHREF=http://c.moreover.com/click/here.pl%3fz2518029065%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000457&HITNO=9&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000457&THISHREF=http://c.moreover.com/click/here.pl%3fz2518029065%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInternational Business Times: BRIEF-US FDA warns Millipore on H1N1 flu product promotionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998601&HITNO=10&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998601&THISHREF=http://c.moreover.com/click/here.pl%3fz2517139747%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998601&HITNO=10&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998601&THISHREF=http://c.moreover.com/click/here.pl%3fz2517139747%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInteractive Investor: First Treatment to Improve Survival in 20 Years Now Available for Patients with Osteosarcoma (Bone Cancer)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3990400&HITNO=11&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3990400&THISHREF=http://c.moreover.com/click/here.pl%3fz2513300784%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3990400&HITNO=11&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3990400&THISHREF=http://c.moreover.com/click/here.pl%3fz2513300784%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAsahi.com: Vasculitis: Researchers from Albany Medical College detail findings in vasculitishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3988516&HITNO=12&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3988516&THISHREF=http://c.moreover.com/click/here.pl%3fz2511141067%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3988516&HITNO=12&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3988516&THISHREF=http://c.moreover.com/click/here.pl%3fz2511141067%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Watson Completes Acquisition of Eden Biodesignhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3988794&HITNO=13&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3988794&THISHREF=http://c.moreover.com/click/here.pl%3fz2511526260%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3988794&HITNO=13&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3988794&THISHREF=http://c.moreover.com/click/here.pl%3fz2511526260%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Watson completes acquisition of Eden Biopharm Group for US$ 15mnhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987306&HITNO=14&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987306&THISHREF=http://c.moreover.com/click/here.pl%3fz2509767336%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987306&HITNO=14&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Pan%20Diagnostics%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987306&THISHREF=http://c.moreover.com/click/here.pl%3fz2509767336%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: